Mei-Hua Hsu

Title: Mei-Hua Hsu: Innovator in Pneumococcal Disease Prevention

Introduction

Mei-Hua Hsu is a prominent inventor based in Taoyuan, Taiwan. She has made significant contributions to the field of medical science, particularly in the diagnosis and prevention of pneumococcal diseases. With a total of 2 patents, her work is paving the way for innovative treatments and diagnostic methods.

Latest Patents

One of Mei-Hua Hsu's latest patents is a method of diagnosing and preventing pneumococcal diseases using pneumococcal neuraminidases. This method involves administering a composition that includes a combination of three recombinant pneumococcal neuraminidases: NanA, NanB, and NanC of strains CGSP14. The administration of these recombinant neuraminidases elicits an immune response, providing protection against pneumococcal infection. Additionally, the method includes steps for enhancing the immune response with adjuvants and utilizing passive antibodies generated from neuraminidases-immunized humanized animals. This invention also offers a molecular diagnosis method for pneumococcal infection.

Career Highlights

Mei-Hua Hsu is affiliated with the Chang Gung Medical Foundation, Linkou Branch, where she continues her research and development efforts. Her work is instrumental in advancing medical treatments and improving patient outcomes.

Collaborations

Mei-Hua collaborates with notable colleagues, including Cheng-Hsun Chiu and Rajendra Prasad Janapatla. These partnerships enhance her research capabilities and contribute to the success of her innovative projects.

Conclusion

Mei-Hua Hsu's contributions to the field of pneumococcal disease prevention and diagnosis exemplify her dedication to medical innovation. Her patents reflect a commitment to improving healthcare and advancing scientific knowledge.